Related Experiment Video
Updated: Feb 12, 2026

An Image Guided Transapical Mitral Valve Leaflet Puncture Model of Controlled Volume Overload from Mitral Regurgitation in the Rat
Published on: May 19, 2020
Long-term outcomes of mitral valve annuloplasty versus subvalvular sparing replacement for severe ischemic mitral
Baotong Li1, Hengchao Wu1, Hansong Sun2
1State Key Laboratory of Cardiovascular Disease, Department of Adult Cardiac Surgery, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Science, Peking Union Medical College, Beijing, China.
Insights
For severe chronic ischemic mitral regurgitation (CIMR), subvalvular sparing mitral valve replacement (MVR) shows better ventricular remodeling and fewer heart failure hospitalizations compared to mitral valve annuloplasty (MVA). Long-term outcomes were similar for major adverse events and survival.
Area of Science:
- Cardiovascular Surgery
- Interventional Cardiology
- Cardiac Surgery Outcomes
Background:
- Severe chronic ischemic mitral regurgitation (CIMR) management guidelines recommend surgery but lack specificity regarding valve repair versus replacement.
- Mitral valve annuloplasty (MVA) and subvalvular sparing mitral valve replacement (MVR) are surgical options for severe CIMR.
Purpose of the Study:
- To compare the long-term clinical outcomes of MVA versus subvalvular sparing MVR in patients with severe CIMR.
Main Methods:
- Retrospective review of 392 patients with severe CIMR undergoing MVA or subvalvular sparing MVR.
- Multivariable regression analysis and propensity score matching (77 pairs) were used to adjust for baseline differences.
Main Results:
- No significant difference in major adverse cardiac or cerebrovascular events (MACCE), cardiac death, or all-cause death between MVA and MVR groups after adjustment.
- MVA group showed larger left atrium/ventricle diameters and higher mitral regurgitation recurrence rates.
- Subvalvular sparing MVR was associated with a lower incidence of heart failure hospitalization compared to MVA.
Conclusions:
- Subvalvular sparing MVR is a suitable option for severe CIMR, promoting better ventricular remodeling.
- MVR demonstrates a reduced rate of heart failure hospitalization compared to MVA in this patient cohort.
Background:
Although practice guidelines recommend surgery for patients with severe chronic ischemic mitral regurgitation (CIMR), they do not specify whether to repair or replace the mitral valve. The purpose of this study was to evaluate the long-term outcomes in patients with severe CIMR undergoing mitral valve annuloplasty (MVA) versus subvalvular sparing mitral valve replacement (MVR).
Methods:
392 consecutive patients who underwent MVA or subvalvular sparing MVR for treatment of severe CIMR were retrospectively reviewed.
Results:
After adjustment for baseline differences with multivariable regression analysis at 53 months follow-up (interquartile range, 34-81 months), there was no significant difference between the two groups for risk of major adverse cardiac or cerebrovascular events (MACCE), cardiac death, or all-cause death. Propensity score matching extracted 77 pairs. During the follow-up, compared with the MVR group, both the left atrium and left ventricle end-diastolic diameter were markedly larger (p = 0.013 and p = 0.033, respectively), and the incidence of mitral regurgitation recurrence was significantly higher in the MVA group (p < 0.001). No significant difference was observed between the two propensity score-matched groups in composite in-hospital outcomes, overall survival, freedom from cardiac death or MACCE, except subvalvular sparing MVR was associated with a lower incidence of hospitalization for heart failure than MVA (p = 0.015).
Conclusions:
Subvalvular sparing MVR is a suitable management of patients with severe CIMR, it is more favorable to ventricular remodeling and is associated with a lower incidence of hospitalization for heart failure than MVA.
Related Concept Videos
Mitral Regurgitation I: Introduction
Mitral Valve Prolapse I: Introduction
Mitral Regurgitation III: Medical Management
Mitral Regurgitation IV: Nursing Management
Mitral Valve Prolapse II: Assessment and Management
Mitral Regurgitation II: Clinical Features and Diagnostic Tests

